Loading Events

« All Events

  • This event has passed.

Oral Drug Formulation Innovations Summit

November 5, 2014 - November 6, 2014

[vc_row][vc_column width=”1/2″][vc_text_separator title=”Event Summary” title_align=”separator_align_left” color=”grey”][vc_column_text]

Uncovering the Future of Formulation Development, Oral Drug Delivery and Innovative Strategies to Accelerate Drug Product Time-To-Market

** Please note, there is limited remaining room availability at the Westin San Diego. We advise attendees to register ASAP to secure the Curtis & Coulter reduced rate before October 22nd. **


With the growth of generic drugs and biosimilars, not to mention an ever-complicated regulatory landscape, the reign of the blockbuster drug is diminishing. Drug developers are under more pressure than ever to push new compounds through development in an effort to see a return on their investments. Many new poorly-soluble compounds require significant formulation in order to maximize bioavailability and exposure. Oral products continue to dominate today’s commercial market. With many recent advances in formulation strategy and technology design, the choices are endless. But how do you know what is the most effective formulation strategy for your future compound?

Curtis & Coulter’s Oral Drug Formulation Innovations Summit will examine and showcase the industry’s latest formulation and delivery technologies for enhancing solubility and maximizing bioavailability. Learn directly from leading global formulation experts in both industry and academia on how to effectively develop poorly soluble drugs into scientifically unique, compliant, patient-centric formulations. Additionally, learn innovative strategies to significantly reduce product development timelines, brush up on the latest regulatory requirements and learn multiple innovative strategies to optimize and enhance your product portfolio.

Join the industry’s leading drug development professionals to discuss and hear unique take-home examples, case studies and multiple formulation and delivery strategies to assist in reducing time-to-market on future drug products. This must-attend event is co-located with Curtis & Coulter’s Bioequivalence: Intersection between Science & Regulatory Conference. Attendees have access to both events in the same location.[/vc_column_text][/vc_column][vc_column width=”1/2″][vc_text_separator title=”Get Registered” title_align=”separator_align_left” color=”grey”][vc_column_text]

[/vc_column_text][vc_text_separator title=”Sponsors” title_align=”separator_align_left” color=”grey”][vc_column_text][soliloquy id=”676″][/vc_column_text][vc_text_separator title=”Event Partners” title_align=”separator_align_left” color=”grey”][vc_column_text][soliloquy id=”682″]

Interested in becoming an event or media partner?

For a full list of event partnership opportunities, please visit here and email info@curtiscoulter.com or call +1 (781) 499-2685[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column width=”1/1″][vc_separator color=”grey”][vc_tabs][vc_tab title=”Agenda at a Glance” tab_id=”1409700672-1-78″][vc_column_text]

Agenda at a Glance

Click Here For Basic Program agenda

  • Breakthrough innovations in the next generation of drug products: A new  thinking for formulation design
  • Creating next generation products: Evaluating innovations in oral drug formulation and delivery technologies
  • Beyond the pill: Addressing future patient needs through the importance of pharmaceutical profiling
  • Understanding and establishing the right conditions for IVIVC correlation
  • Utilizing nanoparticles for the development of the next generation of drug products
  • Effective formulation development strategies for improving oral  bioavailability of poorly water-soluble drugs
  • Enhancing oral formulation and process development timelines: Integrated computational materials science approaches in drug development
  • Sustaining supersaturation of a high energy form of a poorly soluble compound
  • Characterization of amorphous materials to advance product development
  • Spray-dried dispersion formulations in suspensions and solid dosage forms
  • Combining In-Vivo animal models with physiologically-based PBPK modeling
  • Novel Life Cycle management strategies for poorly soluble drugs

[/vc_column_text][/vc_tab][vc_tab title=”Benefits of Attending” tab_id=”1409700672-2-69″][vc_column_text]

Benefits of Attending:

  • 45+ industry-led speaker faculty over 2 full days sharing innovative drug development take-home strategies
  • 120+ senior participants spanning pharma, biotech, and specialty technology companies
  • 5+ hours of networking and breakout sessions, including evening cocktail reception
  • Exhibit hall with multiple leading formulation and bioequivalence providers

[/vc_column_text][/vc_tab][vc_tab title=”Speakers” tab_id=”1409700888807-2-3″][vc_column_text]


Hear from 25+ leading drug formulation innovators including:

  • Riccardo Panicucci, PhD, Global Head, Chemical and Pharmaceutical Profiling, Novartis
  • Eric Munson, PhD, Patrick DeLuca Endowed Professor of Pharmaceutical Technology, University of Kentucky
  • Stefan Proniuk, PhD, Vice President, Product Development, Arno Therapeutics
  • Handan He, PhD, Director, Head, Pharmacokinetics and Pharmacodynamics (PK/PD), Novartis
  • Vijay Gupte, PhD, Associate Director, Formulation Development, Takeda
  • Shirlynn Chen, PhD, Senior Research Fellow, Pharmaceutics, Boehringer Ingelheim
  • Mark Wilson, PhD, Director, Collaboration Management, Europe, Platform Technology and Science, GlaxoSmithKline
  • Sharad Murdande, PhD, Principal Scientist, Pharmaceutical Development, Lifecycle Management, Pfizer, Inc.
  • Ryan M. Doxey, PhD, Head Preformulation & Formulation Group, Novan Therapeutics
  • Ilgaz Akseli, PhD, MBA, Senior Principal Scientist, Boehringer Ingelheim
  • Akash Jain, PhD, Senior Scientist I, Discovery Pharmaceutics, Cubist Pharmaceuticals
  • Pranav Gupta, PhD, Principal Scientist, Pharmaceutical Sciences, Merck Research Labs (MRL), Merck and Co.
  • Weiguo Dai, PhD, Scientific Director, Drug Product Development, Janssen Research & Development, Johnson and Johnson
  • Adnan Sabir, M.S., RPh, QA-CMC Manager, Kowa Pharmaceuticals America, Inc.
  • Kurt Van Scoik, PhD, Research Fellow Eli Lilly and Company
  • Adam Feiler, PhD, Chief Technical Officer, Nanologica
  • And many more…

Interested in presenting at this focused event? Our speaker programs are carefully researched each year to ensure that delegates are exposed to the highest level of expertise. However, delegates not only benefit from the experience of our speakers, but also gain an insight into the experiences of other attendees.
Q&A sessions and panel discussions are utilized to enable sharing of knowledge and facilitate idea exchange.

If you have a cutting edge case study or relevant presentation and are interested in joining the speaker faculty at one of our events, please email info@curtiscoulter.com. Q&A sessions and panel discussions are also utilized to enable sharing of knowledge and facilitate idea exchange.

Please note that due to the high volume of submissions we receive, places on the speaking faculty are extremely limited and subject to approval via our conference advisory committee. Solution providers submissions should contact Mark Coulter at mark@curtiscoulter.com.[/vc_column_text][/vc_tab][vc_tab title=”Who Should Attend?” tab_id=”1409700890755-3-7″][vc_column_text]

Who Should Attend

Pharmaceutical, biotech, CRO, diagnostic and academic professionals specializing in:

  • Drug Delivery
  • Product Development
  • Formulation / Pre-Formulation
  • Structure and Informatics
  • Pharmaceutical Development
  • Technology Assessment
  • PK / PD
  • Medicinal Chemistry
  • Licensing
  • Outsourcing
  • Partnering / Alliance Management
  • Regulatory Affairs
  • Lifecycle Management
  • External Manufacturing

[/vc_column_text][/vc_tab][vc_tab title=”Sponsors” tab_id=”1409816381677-4-7″][vc_column_text][stag_columns]

[stag_one_fourth]GRACE_logo[/stag_one_fourth] [stag_three_fourth_last]Grace is a premier fine chemicals and materials company that specializes in providing innovative products, technologies and services. Grace’s Discovery Sciences business has a portfolio of products and services to support the pharmaceutical manufacturing industry including Syloid® formulation excipients, Vydac® and Davisil® bulk purification media and Multipacker® DAC column packing. Grace also provides a complimentary offering of HPLC and flash purification columns and instruments to support pre-clinical and clinical pharmaceutical development.[/stag_three_fourth_last]

[stag_one_fourth]Skye-Logo (1)[/stag_one_fourth] [stag_three_fourth_last]Skyepharma is an expert oral and inhalation drug delivery company and combines proven scientific expertise with validated proprietary drug delivery technologies and know how. We develop new innovative drug products covering unmet medical needs and support our partners from early feasibility work to commercial manufacturing. Currently 16 products using Skyepharma’s technologies are marketed throughout the world by big pharma as well as speciality pharmaceutical companies.[/stag_three_fourth_last]

[stag_one_fourth]Screenshot 2014-09-15 08.34.48[/stag_one_fourth] [stag_three_fourth_last]Enteris BioPharma: Our simple, elegant and scalable oral delivery solution offers formulation solutions to partners based on our proprietary technology platform.

Our oral delivery technology, which has been validated in late stage clinical trials, significantly enhances the permeability and solubility of peptide therapeutics as well as small molecule drugs.

We are dedicated to building long term strategic relationships and offer our partners a robust, patented and optimized tablet formulation and provide cGMP clinical trial supplies.[/stag_three_fourth_last]

[stag_one_fourth]Crystallics[/stag_one_fourth] [stag_three_fourth_last]Crystallics is a CRO specialized in the optimization of the drug substance physical forms including salts, polymorphs, amorphous forms and co-crystals. Our services also include preformulation activities such as solubility, stability and excipient compatibility studies. In addition, we assist with the scale-up, miniaturization and troubleshooting, including filtration and polymorph issues, in the crystallization process. Our services are based on unique and proprietary hardware and software technologies and these technologies together with strong customer focus and over 14 years of experience has established Crystallics as a leader in this field of research.[/stag_three_fourth_last]

[stag_one_fourth]nanologica_logo[/stag_one_fourth] [stag_three_fourth_last]Nanologica is a Swedish nanotechnology and advanced materials company focused on development of mesoporous silica for applications in therapeutics and drug delivery. Our patented technology platform enables tailor-made solutions for controlled release and enhanced bioavailability. With cutting-edge research we fine-tune silica particles and their inner porous network, to fit the APIs and commercial needs of our partners. The last two years Nanologica has built collaborations with world leading pharmaceutical companies and gone from a research organization to a production-ready company. The next step being partnering-up to bring pre-clinical studies through the clinic to the patient.[/stag_three_fourth_last]


Curtis & Coulter have limited sponsorship opportunities available to help showcase your solutions and services in front of the event delegation. Whether it is showing industry leadership through a speaking engagement, promoting your brand in creative ways throughout the event, hosting a networking reception, or exhibiting your products / services, please feel free to contact Mark Coulter at mark@curtiscoulter.com or call +1 (781) 499-2685 to arrange a needs assessment.*

* Please note that sponsorship opportunities are limited due to the educational-led focus of this event. Please enquire for availability.[/vc_column_text][/vc_tab][vc_tab title=”Event Partners” tab_id=”1409816402634-5-5″][vc_column_text][stag_columns]

[stag_one_fourth]dissolution-technologies[/stag_one_fourth] [stag_three_fourth_last]Dissolution Technologies is a peer reviewed quarterly publication reporting ongoing, useful information on dissolution testing. It provides an international forum for dissolution analysts to receive and exchange information on various dissolution topics.[/stag_three_fourth_last]
[stag_one_fourth]technology-networks[/stag_one_fourth] [stag_three_fourth_last]Technology Networks were established over 10 years ago with the aim of providing informative websites for life science professionals. From our UK headquarters near Sudbury, in Suffolk, we run, update and provide an outstanding web-based information solution for those working within the Life Science and Drug Discovery community. Since its humble beginnings running just one website based on Combinatorial Chemistry, Technology Networks has expanded its portfolio to include over 30 communities. All of which are available through[/stag_three_fourth_last]
[stag_one_fourth]Screenshot 2014-09-04 00.55.20[/stag_one_fourth] [stag_three_fourth_last]The Information Source for the Pharmaceutical Manufacturing Industry. Welcome to Pharmaceutical Online, the premier sourcing site for the pharmaceutical manufacturing industry, find industry information on critical environment, particle sizing, pharma process control, pharma material handling, tablet production, pharma sterilizing, pharma cleaning, pharma filtration, pharma packaging, pharma inspection, & much more. Use our supplier directory, product showcase, and offline search service to expedite your discovery of new products and services. Our goal is to help buyers, like you, identify and select suppliers. Over the years, Pharmaceutical Online has achieved an unparalleled reputation for the development, organization, and presentation of information for the  pharmaceutical industry. Visitors are enriched with valuable information that can improve your business and make it more profitable. Please take a moment to join our community and discover the benefits of your free membership.[/stag_three_fourth_last]

[stag_one_fourth]Bentham[/stag_one_fourth] [stag_three_fourth_last]Bentham Science Publishers have gained a longstanding international reputation for their excellent standards and top quality scientific publications. Many journals published by Bentham Science have received high impact factors in their respective fields. For the current list of print, online, and open access publications, please visit www.benthamscience.com.

A Bentham Science online newsletter, BenSci, gives news and updates in all fields of social and natural sciences, technology and medicine.


[stag_one_fourth]pharmaphorum (3)[/stag_one_fourth] [stag_three_fourth_last]pharmaphorum drives innovation within the pharmaceutical industry, by bringing healthcare together through a suite of media services that help produce and disseminate thought leadership, combined with an online platform for communicating messages to a global audience.[/stag_three_fourth_last]
[stag_one_fourth]Contract-pharma[/stag_one_fourth] [stag_three_fourth_last]Every week, thousands of pharma and biopharma outsourcing professionals go to www.contractpharma.com to read current features, find stories in the archives, get breaking news and online exclusives, download surveys, Top Companies reports and whitepapers, search the Contract Services Directory and find useful links to other important content. These users are a highly targeted audience that comes back time and again for insights into this marketplace and into your products and services.[/stag_three_fourth_last]
[stag_one_fourth]pm360_logo[/stag_one_fourth] [stag_three_fourth_last]

PM360 is the premier, must-read monthly magazine for marketing decision makers in the pharmaceutical, biotech, and medical device industries. PM360 is the only journal that delivers practical how-to marketing information necessary for product managers/pharma marketing professionals to succeed in the complex and regulated healthcare environment. For more information, please visit: www.pm360online.com.


[stag_one_fourth]iptechex_pharmalicensing_logo[/stag_one_fourth] [stag_three_fourth_last]Pharmalicensing is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide. Actively supporting all forms of partnering and in- and out-licensing activities, Pharmalicensing utilizes the unique Partnering Search service and its global network of industry experts to enable companies to identify and engage with appropriate partners around the world. Pharmalicensing, and its sister service Medical Device Licensing are actively utilized by over 200,000 industry professionals each month. Pharmalicensing is a division of IP Technology Exchange, Inc.[/stag_three_fourth_last]
[stag_one_fourth]mnt_logo[/stag_one_fourth] [stag_three_fourth_last]Media News Today is the largest independent medical and health news site on the web – with over 8,000,000 monthly unique users it is ranked number one for medical news on all major search engines. Medical News Today is used by pharmaceutical, biotech and health organizations, advertising agencies, PR companies and vertical ad networks to deliver targeted disease/condition and general health campaigns. For more information contact peter@medicalnewstoday.com or visit www.medicalnewstoday.com.[/stag_three_fourth_last]

[stag_one_fourth]PharmaVoice[/stag_one_fourth] [stag_three_fourth_last]PharmaVOICE.com is a Website for life-sciences executives and other healthcare-service related professionals. PharmaVOICE.com is produced by PharmaLinx LLC, publishers of PharmaVOICE magazine and the VIEWs.The primary audience is made up of executive and corporate management from pharmaceutical, biotechnology, drug delivery, marketing communications, clinical services, contract research, drug development, and information technology companies.PharmaVOICE.com provides access to all of the articles that have appeared in the print publications of PharmaVOICE and the VIEWs. PharmaVOICE.com also provides an online calendar of industry events, an online discussion forum, a monthly interactive opinion poll, and other online content, supported by a robust search engine.


[stag_one_fourth]farmavitanet_logo[/stag_one_fourth] [stag_three_fourth_last]Farmavita Net is professional community and network of pharmaceutical licensing and business development executives, innovators and researchers. We are managing the marketplace of offers and demand for pharmaceutical Dossiers, know-how and technologies. Farmavita.Net is not just a pure Internet portal. We manage a number of regional associates. We are connecting the dynamic network of few hundreds members / pharmaceutical companies interested in license-in and license-out opportunities.[/stag_three_fourth_last]

[/stag_columns][/vc_column_text][/vc_tab][/vc_tabs][vc_text_separator title=”Event Pricing” title_align=”separator_align_left” color=”grey”][/vc_column][/vc_row][vc_row][vc_column width=”1/2″][vc_column_text css_animation=”bottom-to-top”][stag_alert style=”blue”]Standard Pricing[/stag_alert]

[stag_alert style=”blue”]Conference Only: $2195[/stag_alert][/vc_column_text][/vc_column][vc_column width=”1/2″][vc_column_text css_animation=”bottom-to-top”][stag_alert style=”blue”]On-Site Pricing

[stag_alert style=”blue”]Conference Only: $2295[/stag_alert][/vc_column_text][vc_text_separator title=”Register For Event” title_align=”separator_align_left” color=”grey”][vc_column_text css_animation=”bottom-to-top”]event-reg-button[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column width=”1/1″][vc_text_separator title=”Group Discounts Available” title_align=”separator_align_left” color=”grey”][vc_column_text]

Save 25% per person when registering four people from your company. For every three simultaneous registrations, you will receive a fourth complimentary registration to the program (must register 4 at one time). This is a savings of 25% per person. Terms and Conditions

[/vc_column_text][vc_text_separator title=”Event Venue and Details” title_align=”separator_align_left” color=”grey”][/vc_column][/vc_row]


November 5, 2014
November 6, 2014